Background

Recent work shows that calreticulin and ERp57 decline with age across mouse tissues, leading to chronic IRE1 arm activation (increased XBP1 splicing) and heightened JNK‑mediated apoptosis [1, 2]. In skeletal muscle, the PERK arm is required for satellite cell survival and myogenic differentiation, whereas the IRE1/XBP1 arm is dispensable [3]. However, the adaptive UPR response to exercise is blunted in older adults, indicating a loss of protective PERK signaling when needed [4]. ER structure also remodels via ER‑phagy during aging [5]. These observations raise the possibility that the ratio of IRE1 to PERK activity, rather than absolute ER stress levels, dictates whether ER‑phagy promotes clearance or triggers deleterious satellite cell loss.

Hypothesis

We hypothesize that aging increases the IRE1‑PERK activity ratio, which skews ER‑phagy toward selective degradation of PERK‑associated ER subdomains. This loss of PERK‑resident ER impairs the local translation of ATF4‑dependent survival factors in satellite cells, tipping the balance toward apoptosis despite unchanged global ER load.

Mechanistic model

1. Chaperone loss (calreticulin/ERp57) triggers luminal sensing by IRE1, promoting its oligomerization and sustained RNase activity [1].
2. Persistent IRE1 signaling recruits TRAF2‑ASK1‑JNK complexes, amplifying pro‑apoptotic cues [2].
3. Elevated IRE1 activity drives phosphorylation of the ER‑phagy receptor FAM134B at a serine residue that enhances its affinity for PERK‑rich ER sheets (novel post‑translational modification inferred from kinase‑substrate predictions).
4. Selective ER‑phagy removes PERK‑containing ER domains, decreasing local PERK autophosphorylation and reducing eIF2α‑ATF4 translation of chaperones and antioxidant genes.
5. Satellite cells experience a cell‑autonomous deficit in PERK‑mediated adaptive responses, rendering them susceptible to JNK‑driven apoptosis during regenerative stress.

Testable predictions

• Prediction 1: In aged mouse skeletal muscle, immunofluorescence will show reduced colocalization of PERK with ER‑phagy markers (LC3, FAM134B) compared with young tissue, while IRE1 remains associated with ER‑phagy sites.
• Prediction 2: Genetic or pharmacological reduction of IRE1 RNase activity (e.g., with MKC8866) in aged mice will restore PERK‑ER density, increase ATF4 target expression, and improve satellite cell proliferation after injury.
• Prediction 3: Overexpression of a phospho‑deficient FAM134B mutant (Ser→Ala) in aged satellite cells will prevent selective PERK‑ER loss and rescue myogenic differentiation despite chronic ER stress.
• Prediction 4: Measuring the IRE1‑PERK activity ratio (XBP1s/(p‑PERK+ATF4) ratio) in human muscle biopsies will correlate inversely with regenerative capacity across age groups.

Experimental approach

1. Mouse models: Use aged (24 mo) wild‑type, IRE1‑knockdown (muscle‑specific shRNA), and FAM134B‑S/A knock‑in mice. Induce muscle injury via cardiotoxin and assess satellite cell proliferation (Pax7+/Ki67+), differentiation (Myosin Heavy Chain+), and apoptosis (TUNEL).
2. Biochemical assays: Quantify XBP1 splicing, p‑PERK, ATF4, and LC3‑II levels in isolated muscle fractions. Perform proximity ligation assays to detect PERK‑FAM134B interactions.
3. Human validation: Obtain vastus lateralis biopsies from young (20‑30 yr) and old (>70 yr) donors. Measure the IRE1‑PERK activity ratio by RT‑qPCR for XBP1s and ATF4, and correlate with ex vivo satellite cell colony‑forming efficiency.
4. Rescue experiments: Treat aged mice with the PERK activator CCT020312 or with a JNK inhibitor (SP600125) to test whether enhancing PERK signaling or blocking downstream apoptosis ameliorates the phenotype.

Potential confounds and controls

• Global ER stress: Ensure that observed changes are not due to overt ER overload by measuring BiP/GRP78 levels; if BiP is unchanged, effects are likely ratio‑specific.
• Compensatory UPR branches: Monitor ATF6 signaling to rule out compensatory activation that could mask PERK loss.
• Cell‑non‑autonomous effects: Use satellite‑cell‑specific Cre lines to isolate intrinsic mechanisms from inflammatory milieu.

If the IRE1‑PERK ratio governs selective ER‑phagy and satellite cell fate, manipulating this ratio should uncouple chronic ER stress from regenerative decline, offering a novel therapeutic angle for sarcopenia.